[Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
D000328:Adult; D000937:Antigen-Antibody Reactions; D002231:Carbimazole / Q000627:therapeutic use; D005094:Exophthalmos; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000276:immunology* / Q000628:therapy*; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007456:Iodine Isotopes / Q000627:therapeutic use; D008135:Long-Acting Thyroid Stimulator / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D013954:Thyroglobulin; D005719:gamma-Globulins / Q000032:analysis*
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007456:Iodine Isotopes; D005719:gamma-Globulins; D002231:Carbimazole; D013954:Thyroglobulin; D008135:Long-Acting Thyroid Stimulator
Evolution des immunoglobulines IgA, IgM, IgG et du LATS au cours du traitement des hyperthyroïdies par le carbimazol et par le radioiode.